Sara Bilekova

Sara Bilekova

Auto-generated profile, based on publicly available information

Sara Bilekova

Institute of Diabetes and Regeneration Research, Helmholtz Center Munich, Neuherberg, Germany

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 April 2021 in Cell
Verified
Journal Article
Closed access
MTMelissa E. Truong
Melissa E. Truong
SBSara Bilekova
Sara Bilekova
SCSemil P. Choksi
Semil P. Choksi
WLWan Li
Wan Li
LBLukasz J. Bugaj
Lukasz J. Bugaj
JRJeremy F. Reiter
Jeremy F. Reiter

27 January 2021 in Nature
Verified
Journal Article
Closed access
PDF file
ANAnsarullah
Ansarullah
Chirag JainChirag Jain
Chirag Jain
FFFataneh Fathi Far
Fataneh Fathi Far
SHSarah Homberg
Sarah Homberg
KWKatharina Wissmiller
Katharina Wissmiller
HLHeiko Lickert
Heiko Lickert
1

21 September 2022 in Nature Metabolism
Verified
Journal Article
Closed access
PDF file
Chirag JainChirag Jain
Chirag Jain
ANAnsarullah
Ansarullah
SBSara Bilekova
Sara Bilekova
HLHeiko Lickert
Heiko Lickert
1

25 November 2024 in Nature Metabolism
Verified
Journal Article
Open access
PDF file
JSJohanna Siehler
Johanna Siehler
SBSara Bilekova
Sara Bilekova
PCPrisca Chapouton
Prisca Chapouton
ADAlessandro Dema
Alessandro Dema
PAPascal Albanese
Pascal Albanese
HLHeiko Lickert
Heiko Lickert
Blunted first-phase insulin secretion and insulin deficiency are indicators of β cell dysfunction and diabetes manifestation. Therefore, insights into molecular mechanisms that regulate insulin homeostasis might provide entry sites to replenish insulin content and restore β cell function. Here, we identify the insulin inhibitory receptor (inceptor; encoded by the gene IIR/ELAPOR1) as an insulin-binding receptor that regulates insulin stores by lysosomal degradation. Using human induced pluripotent stem cell (SC)-derived islets, we show that IIR knockout (KO) results in enhanced SC β cell differentiation and survival. Strikingly, extended in vitro culture of IIR KO SC β cells leads to greatly increased insulin content and glucose-stimulated insulin secretion (GSIS). We find that inceptor localizes to clathrin-coated vesicles close to the plasma membrane and in the trans-Golgi network as well as in secretory granules, where it acts as a sorting receptor to direct proinsulin and insulin towards lysosomal degradation. Targeting inceptor using a monoclonal antibody increases proinsulin and insulin content and improves SC β cell GSIS. Altogether, our findings reveal the basic mechanisms of β cell insulin turnover and identify inceptor as an insulin degradation receptor.

28 February 2024 in Nature Metabolism
Verified
Journal Article
Open access
PDF file
GGGerald Grandl
Gerald Grandl
GCGustav Collden
Gustav Collden
JFJin Feng
Jin Feng
SBSreya Bhattacharya
Sreya Bhattacharya
FKFelix Klingelhuber
Felix Klingelhuber
Timo D. MüllerTimo D. Müller
Timo D. Müller
Insulin resistance is an early complication of diet-induced obesity (DIO)1, potentially leading to hyperglycaemia and hyperinsulinaemia, accompanied by adaptive β cell hypertrophy and development of type 2 diabetes2. Insulin not only signals via the insulin receptor (INSR), but also promotes β cell survival, growth and function via the insulin-like growth factor 1 receptor (IGF1R)3–6. We recently identified the insulin inhibitory receptor (inceptor) as the key mediator of IGF1R and INSR desensitization7. But, although β cell-specific loss of inceptor improves β cell function in lean mice7, it warrants clarification whether inceptor signal inhibition also improves glycaemia under conditions of obesity. We assessed the glucometabolic effects of targeted inceptor deletion in either the brain or the pancreatic β cells under conditions of DIO in male mice. In the present study, we show that global and neuronal deletion of inceptor, as well as its adult-onset deletion in the β cells, improves glucose homeostasis by enhancing β cell health and function. Moreover, we demonstrate that inceptor-mediated improvement in glucose control does not depend on inceptor function in agouti-related protein-expressing or pro-opiomelanocortin neurons. Our data demonstrate that inceptor inhibition improves glucose homeostasis in mice with DIO, hence corroborating that inceptor is a crucial regulator of INSR and IGF1R signalling.

8 May 2026 in Nature Communications
Verified
Journal Article
Open access
PDF file
KKKarsten Krey
Karsten Krey
JRJennifer Risso-Ballester
Jennifer Risso-Ballester
SHSabri Hamad
Sabri Hamad
SMSusanne Maidl
Susanne Maidl
SBSara Bilekova
Sara Bilekova
APAndreas Pichlmair
Andreas Pichlmair
The innate immune system requires the activity of interferon-stimulated genes (ISGs) to mount its protective response against viruses. However, the activity of ISGs against viruses varies widely and is orchestrated by the interplay of hundreds of ISGs. Utilizing a time-resolved, arrayed loss-of-function screen, we systematically investigate 285 ISGs for their virus-modulating activity against eight viruses. The quantitated data from the screen results do not necessarily result in similar quantitative biological effects of gene function but indicates virus specificity of many ISGs and pan-proviral activity of some ISGs, such as RNA 2’,3’-cyclic phosphate and 5’-OH ligase (RTCB). Co-depletions of selected candidates identify ISGs with synergistic functions, highlighting particularly strong synergies between ISGs inhibiting entry pathways and ISGs involved in IFN signaling. Among unexplored ISGs, we identify BORCS8, which has a particularly prominent role in modulating SARS-CoV-2 infection. Mechanistically, BORCS8 mediates the acidification of early endosomes during viral entry, a process known to facilitate the degradation of virus particles. Collectively, this extensive resource reveals specificities of ISGs identified in this screening system and suggests potential strategies for antiviral treatment options.